Clinical Trials Browser

Phase 2 × Melanoma × nilotinib × Clear all

NCT00788775 2018-11-15

Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma

Phase 2 Completed

20 enrolled 14 charts

Melanoma

NCT01028222 2015-12-30

TEAM

Phase 2 Completed

55 enrolled 13 charts

Melanoma

NCT01168050 2011-02-08

NILOMEL

Phase 2 Unknown

Melanoma